[HTML] from nih.govM Shuda, HJ Kwun, H Feng, Y Chang… - The Journal of clinical …, 2011 - ncbi.nlm.nih.gov Merkel cell polyomavirus (MCV) is the recently discovered cause of most Merkel cell carcinomas (MCCs), an aggressive form of nonmelanoma skin cancer. Although MCV is known to integrate into the tumor cell genome and to undergo mutation, the molecular mechanisms used by ... Cited by 1
T Nicholaou, W Chen, ID Davis… - Cancer Immunology, …, 2011 - Springer Abstract Background NY-ESO-1 protein formulated in ISCOMA- TRIXTM results in CD4?, CD8? T cell and antibody- mediated immunity. We evaluated persistence of immunity, relapse-free survival and tumour antigen expression upon relapse in patients vaccinated ... Related articles - All 2 versions
IF San Francisco, L Werner, MM Regan… - The Journal of …, 2011 - Elsevier Of the cohort 30% progressed during a median of 2.4 years. Three multivariate analyses were performed. The first analysis used variables only at diagnosis biopsy and revealed that prostate specific antigen density greater than 0.08 ng/ml/cc and prostate cancer family history ... Cited by 3 - Related articles - All 7 versions
[HTML] from pnas.orgS Hiratsuka, DG Duda, Y Huang… - Proceedings of the …, 2011 - National Acad Sciences Increasing evidence suggests that myeloid bone marrow-derived cells (BMDCs) play a critical role in lung metastasis. Blockade of VEGF receptor 1 (VEGFR1) has been proposed as a potential strategy to limit myeloid BMDC recruitment to tumors. However, preclinical evidence ... Cited by 4 - Related articles - All 5 versions
JF Banchereau, F Berard, P Blanco… - US Patent …, 2011 - Google Patents (12) United States Patent Banchereau et al. USO07988963B1 (10) Patent No.: US 7,988,963 B1 (45) Date of Patent: Aug. 2, 2011 (54) USE OF ALLOGENEIC CELL LINES TO LOAD ANTIGEN PRESENTING CELLS TO ELICIT OR ELIMINATE IMMUNE RESPONSES (75) Inventors: ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
